Stephen Condon
About Stephen Condon
Stephen Condon, Vice President, Chemistry
Stephen Condon serves as the Vice President of Chemistry. He has dedicated over 25 years to the discovery and development of bioactive compounds. His role involves strategic planning, leadership, and scientific development within the field of chemistry, specifically focusing on bioactive compounds. Condon's work has positioned him as a key figure in advancing research related to cellular signaling pathways and therapeutic agents.
Stephen Condon's Experience at TetraLogic Pharmaceuticals
During his tenure at TetraLogic Pharmaceuticals, Stephen Condon held multiple roles that involved significant leadership and research responsibilities. He led a team of scientists in identifying and evaluating small molecule antagonists of the Inhibitor of Apoptosis (IAP) family of proteins. His collaborative efforts with an international team contributed to major discoveries regarding the role of cellular IAP proteins in TNF signaling, inflammation, and tumor cell death. A notable achievement from this period includes contributing to the discovery of birinapant, a first-in-class bivalent IAP antagonist.
Previous Roles and Achievements in Medicinal Chemistry
Stephen Condon's career in medicinal chemistry includes significant roles at ViroPharma and Rhône-Poulenc Rorer. At ViroPharma, he served as Group Leader in Medicinal Chemistry and was credited with inventing the first HCV NS5B inhibitor to demonstrate efficacy in a humanized mouse model of HCV infection. His early career at Rhône-Poulenc Rorer saw his team determining the bioactive conformation of human parathyroid [1-34] and developing anabolic peptides for treating post-menopausal osteoporosis.
Educational Background and Research
Stephen Condon holds a doctoral degree from the University of Pennsylvania. His dissertation work with Professor Amos B. Smith III focused on the total synthesis of rapamycin and demethoxyrapamycin. This advanced research underlined his foundation in organic synthesis and medicinal chemistry, providing a strong basis for his future career in drug discovery and development.